Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weidong Han

Showing results (181-190 of 392) with videos related to

Pageof 40
Sort By:
Chemical Communications (Cambridge, England)|February 13, 2020
Niacin-ligated platinum(iv)-ruthenium(ii) chimeric complexes synergistically suppress tumor metastasis and growth with potentially reduced toxicity in vivoLiwei Shu, Lulu Ren, Yuchen Wang, et al.
Cancer Letters|February 18, 2015
Epigenetic modifications as regulatory elements of autophagy in cancerXinbing Sui, Jing Zhu, Jichun Zhou, et al.
Science China. Life Sciences|July 27, 2020
Adaptive T cell immunotherapy in cancerDongdong Ti, Miaomiao Bai, Xiaolei Li, et al.
Frontiers in Cell and Developmental Biology|August 5, 2021
Effect of ISM1 on the Immune Microenvironment and Epithelial-Mesenchymal Transition in Colorectal CancerYuhui Wu, Xiaojing Liang, Junjie Ni, et al.
Cancer Science|November 16, 2022
Dual targeted therapy with pyrotinib and trastuzumab for HER2-positive advanced colorectal cancer: A phase 2 trialXianhua Fu, Jieer Ying, Liu Yang, et al.
Experimental and Therapeutic Medicine|June 16, 2023
Efficacy and safety of PD‑1 inhibitor plus antiangiogenic treatment in patients with unresectable biliary tract cancer: A multicenter retrospective studyZhiheng Wu, Xudong Zhu, Xian Zhong, et al.
Cellular & Molecular Immunology|April 27, 2026
Inhibition of glycosphingolipid synthesis overcomes the steric hindrance of CD30 N-glycans to augment CD30-targeted immunotherapeutic efficacyYuting Pan, Yixin Chang, Wanjun Zhang, et al.
Carcinogenesis|November 11, 2011
microRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2Jing Nie, Lin Liu, Wei Zheng, et al.
Oncotarget|April 21, 2015
An open-label, single-arm, phase I/II study of lower-dose decitabine based therapy in patients with advanced hepatocellular carcinomaQian Mei, Meixia Chen, Xuechun Lu, et al.
International Journal of Biological Sciences|October 20, 2022
TMP195 Exerts Antitumor Effects on Colorectal Cancer by Promoting M1 Macrophages PolarizationYicheng Han, Jiachun Sun, Yanyan Yang, et al.
Pageof 40

Showing results (181-190 of 392) with videos related to

Sort By:
Pageof 40
Chemical Communications (Cambridge, England)|February 13, 2020
Niacin-ligated platinum(iv)-ruthenium(ii) chimeric complexes synergistically suppress tumor metastasis and growth with potentially reduced toxicity in vivoLiwei Shu, Lulu Ren, Yuchen Wang, et al.
Cancer Letters|February 18, 2015
Epigenetic modifications as regulatory elements of autophagy in cancerXinbing Sui, Jing Zhu, Jichun Zhou, et al.
Science China. Life Sciences|July 27, 2020
Adaptive T cell immunotherapy in cancerDongdong Ti, Miaomiao Bai, Xiaolei Li, et al.
Frontiers in Cell and Developmental Biology|August 5, 2021
Effect of ISM1 on the Immune Microenvironment and Epithelial-Mesenchymal Transition in Colorectal CancerYuhui Wu, Xiaojing Liang, Junjie Ni, et al.
Cancer Science|November 16, 2022
Dual targeted therapy with pyrotinib and trastuzumab for HER2-positive advanced colorectal cancer: A phase 2 trialXianhua Fu, Jieer Ying, Liu Yang, et al.
Experimental and Therapeutic Medicine|June 16, 2023
Efficacy and safety of PD‑1 inhibitor plus antiangiogenic treatment in patients with unresectable biliary tract cancer: A multicenter retrospective studyZhiheng Wu, Xudong Zhu, Xian Zhong, et al.
Cellular & Molecular Immunology|April 27, 2026
Inhibition of glycosphingolipid synthesis overcomes the steric hindrance of CD30 N-glycans to augment CD30-targeted immunotherapeutic efficacyYuting Pan, Yixin Chang, Wanjun Zhang, et al.
Carcinogenesis|November 11, 2011
microRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2Jing Nie, Lin Liu, Wei Zheng, et al.
Oncotarget|April 21, 2015
An open-label, single-arm, phase I/II study of lower-dose decitabine based therapy in patients with advanced hepatocellular carcinomaQian Mei, Meixia Chen, Xuechun Lu, et al.
International Journal of Biological Sciences|October 20, 2022
TMP195 Exerts Antitumor Effects on Colorectal Cancer by Promoting M1 Macrophages PolarizationYicheng Han, Jiachun Sun, Yanyan Yang, et al.
Pageof 40